Extracellular ATP and Toll-Like Receptor 2 Agonists Trigger in Human Monocytes an Activation Program That Favors T Helper 17

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Paustian, Christopher ^a,e   Taylor, Patricia ^b   Johnson, Terrence ^a   Xu, Min ^c   Ramirez, Nancy ^a   Rosenthal, Kenneth S ^b   Shu, Suyu ^d   Cohen, Peter A ^d,f   Czerniecki, Brian J ^c   Koski, Gary K ^a  

^a KENT STATE UNIVERSITY   (United States)

^b Northeast Ohio Medical University   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e EARLE A CHILES RESEARCH INSTITUTE   (United States)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIUM LIPOPOLYSACCHARIDE; CYCLIC AMP; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; LIPOTEICHOIC ACID;

ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE CULTURE; MONOCYTE; PHENOTYPE; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL;

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CELLS, CULTURED; CHEMOTAXIS; CYTOKINES; DENDRITIC CELLS; DRUG SYNERGISM; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; PHENOTYPE; PROTEIN SUBUNITS; SIGNAL TRANSDUCTION; TEICHOIC ACIDS; TH17 CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84873150304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054804     Document Type: Article

References (72)

1. Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P, (1999) The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy. Clin Exp Allergy 29Suppl 2: 33-36.
2. Manetti RP, Parronchi MG, Giudizi MP, Piccinni E, Maggi G, et al. (1993) Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199-1204.
3. Park AY, Hondowicz B, Kopf M, Scott P, (2002) The role of IL-12 in maintaining resistance to Leishmania major. J Immunol 168: 5771-5777.
4. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
5. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
6. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
7. Bettelli EY, Carrier W, Gao T, Korn TB, Strom M, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
8. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639-646.
9. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957.
10. Aujla SJ, Dubin PJ, Kolls JK, (2007) Th17 cells and mucosal host defense. Semin Immunol 19: 377-382.
11. Pene JS, Chevalier L, Preisser E, Venereau MH, Guilleux S, et al. (2008) Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 180: 7423-7430.
12. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE, (1990) Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 172: 921-929.
13. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
14. Romagnani S, (2006) Regulation of the T cell response. Clin Exp Allergy 36: 1357-1366.
15. Matzinger P, (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991-1045.
16. Medzhitov R, Janeway C Jr, (2000) Innate immune recognition: mechanisms and pathways. Immunol Rev 173: 89-97.
17. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
18. Gallucci S, Matzinger P, (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13: 114-119.
19. Ohashi K, Burkart V, Flohe S, Kolb H, (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164: 558-561.
20. Rashmilewitz J, (2010) Glycosylation: An intrinsic sign of "danger". Self Nonself 1: 250-254.
21. Hanley PJ, Musset B, Renigunta V, Limberg SH, Dalpke AH, et al. (2004) Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages. Proc Natl Acad Sci U S A 101: 9479-9484.
22. Iwase T, Shinji H, Tajima A, Sato F, Tamura T, et al. (2010) Isolation and identification of ATP-secreting bacteria from mice and humans. J. Clin Microbiol 48: 1949-1951.
23. Atarashi K, Nishimur J, Shima T, Umesaki Y, Yamamoto M, et al. (2008) ATP drives lamina propria T(H)17 cell differentiation. Nature 455: 808-812.
24. Berchtold S, Ogilvie AL, Bogdan C, Muhl-Zurbes P, Ogilvie A, (1999) Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett 458: 424-428.
25. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A, (2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 6: 769-776.
26. Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML, (1998) High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 10: 1593-1598.
27. Czerniecki BJ, Carter C, Rivoltini L, Koski GK, Kim HI, (1997) Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 159: 3823-3837.
28. Koski GK, Lyakh LA, Rice NR, (2001) Rapid lipopolysaccharide-induced differentiation of CD14(+) monocytes into CD83(+) dendritic cells is modulated under serum-free conditions by exogenously added IFN-gamma and endogenously produced IL-10. Eur J Immunol 31: 3773-3781.
29. Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, (2007) Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res 67: 1842-1852.
30. Xu S, Koldovsky U, Xu M, Wang D, Fitzpatrick E, (2006) High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL-12 production. Surgery 140: 170-178.
31. Roses RE, Xu S, Xu M, Koldovsky U, Koski G, et al. (2008) Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J Immunol 181: 5120-5127.
32. Koski GK, Kariko K, Xu S, Weissman D, Cohen PA, et al. (2004) Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J Immunol 172: 3989-3993.
33. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, et al. (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. BLOOD 97: 587-600.
34. Lyakh LA, Koski GK, Telford W, Gress RE, Cohen PA, et al. (2000) Bacterial lipopolysaccharide, TNF-alpha, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NK-kappa B. J Immunol. 165: 3647-3655.
35. Liu W, Ouyang X, Yang J, Liu J, Li Q, et al. (2009) AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J Biol Chem 284: 24006-24016.
36. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, et al. (2001) Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69: 1477-1482.
37. Perregaux DG, Laliberte RE, Gabel CA, (1996) Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response. J Biol Chem 271: 29830-29838.
38. Schnurr M, Toy T, Shin A, Wagner M, Cebon J, et al. (2005) Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 105: 1582-1589.
39. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, et al. (2008) A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9: 650-657.
40. Evans HG, Gullick NJ, Kelly S, Pitzalis C, Lord GM, et al. (2009) In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc Natl Acad Sci U S A 106: 6232-6237.
41. Strowig T, Henao-Mejia J, Elinav E, Flavell R, (2012) Inflammasomes in health and disease. Nature 481: 278-86.
42. Maio EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, et al. (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1 beta via lpaf. Nat Immunol. 6: 569-75.
43. Martinon F, Burns K, Tschopp J, (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro IL-1 beta. Mol Cell. 10: 417-426.
44. Agnosti L, Martinon F, Burns K, McDermott MF, Hawkins PN, (2004) NALP3 forms an IL-1 beta-processing inflammasome with increased activity in Muckle-wells autoinflammatory disorder. Immunity 20: 319-325.
45. Gu Y, Tsutsui H, Ku G, Hsiao K, Fleming MA, et al. (1997) Activation of interferon-gamma inducing factor mediated by interleukin 1beta converting enzyme. Science 275: 206-9.
46. Kanneganti TD, Lamkanfi M, Nunez G, (2007) Intracellular NOD-like receptors in host defense and disease. Immunity. 27: 549-59.
47. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, et al. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity and its regulation of caspase-1. Immunity. 24: 317-327.
48. Pelegrin P, Surprenant A, (2006) Pannexin-1 mediates large pore formation and interleukin-1 beta release by the ATP-gated P2X7 receptor. EMBO J. 25: 5071-5082.
49. Brightbill HD, Libraty DH, Krutzik SR, Yang R-B, Belisle JT, et al. (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-36.
50. Lyakh L, Trinchieri G, Provezza L, Carra G, Gerosa F, (2008) Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev. 226: 112-31.
51. Liu FL, Chen CH, Chu SJ, Chen JH, Lai JH, et al. (2007) Interleukin (IL)-23 p19 expression induced by IL-1 beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor kappa B and AP-1 dependent pathway. Rheumatology (Oxford) 46: 1266-1273.
52. Khayrullina T, Yen JH, Jing H, Ganea D, (2008) In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol 181: 721-735.
53. Ouyang W, Kolls JK, Zheng Y, (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467.
54. Martin-Orozco N, Dong C, (2009) The IL-17/IL-23 axis of inflammation in cancer: friend or foe? Curr Opin Investig Drugs 10: 543-549.
55. Duraisingham SS, Hornig J, Gotch F, Patterson S, (2009) TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses. J Immunol 183: 2242-2251.
56. Islander UA, Andersson E, Lindberg I, Adlerberth A, Wold E, et al. (2010) Superantigenic Staphylococcus aureus stimulates production of interleukin-17 from memory but not naive T cells. Infect Immun 78: 381-386.
57. Manel N, Unutmaz D, Littman DR, (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9: 641-649.
58. Balkwill F, Charles KA, Mantovani A, (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211-217.
59. Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, et al. (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3: e2599.
60. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457: 102-106.
61. Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, et al. (2002) The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 277: 20847-20853.
62. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, (1994) Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 343: 258-260.
63. Tokudome S, Hosono A, Suzuki S, Ghadimi R, Tanaka T, et al. (2006) Helicobacter pylori infection as an essential factor for stomach cancer. Asian Pac J Cancer Prev 7: 163.
64. Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL, (2007) Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol 51: 577-586.
65. Zhang B, Rong G, Wei H, Zhang M, Bi J, et al. (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 374: 533-537.
66. Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, et al. (2007) Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol Med Microbiol 51: 140-148.
67. Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, et al. (2009) IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206: 1457-1464.
68. Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, et al. (2006) IL-23 promotes tumour incidence and growth. Nature 442: 461-465.
69. Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, et al. (2009) Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15: 114-123.
70. Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, et al. (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373.
71. Kryczek I, Wei S, Szeliga W, Vatan L, Zou W, (2009) Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114: 357-359.
72. Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, et al. (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114: 1141-1149.